Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBBP8 N-terminal like (gene symbol: RBBP8NL) encodes a protein with homology to the N-terminal region of the RBBP8/CtIP protein, but its biological function is not currently characterized in humans. Its closest paralog, RBBP8 (CtIP), is a well-studied endonuclease and regulator of DNA repair, cell cycle checkpoints, and cancer susceptibility, but there is no evidence that RBBP8NL fulfills similar roles or is considered a therapeutic target. Most databases simply annotate RBBP8NL as a protein coding gene with limited functional data, and it is not documented as a receptor, enzyme, or known drug target[1][3][5][9][10]. RBBP8NL should not be confused with RBBP8 (CtIP), which is a critical DNA repair enzyme and has extensive literature on its roles in cancer biology and as a potential drug target[2][4][6][8][12]. Almost all functional data, biological associations, and disease roles pertain to RBBP8, not RBBP8NL. There is no evidence that RBBP8NL is a validated drug target or biomarker, and no available data on drugs, biomarkers, or mechanisms of action applying specifically to RBBP8NL.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RBBP8 N-terminal like (RBBP8NL).